Total raised
—
Last: Pre-Seed 2025-07
Stage
Pre-Seed
Founded
2024
Headcount
5
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Diastole medical is an Israeli startup, founded by experts in biomedical engineering, medicine and AI, aiming to transform the cardiac diagnostics landscape. Diastole is developing an innovative software platform that harnesses a fusion of ultrasound Doppler technology and AI methodologies to address the need for rapid, accurate, and low-risk detection of coronary disease.
Funding history · 1 round · — total
2025-07
Pre-Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Diastole founded?
- Diastole was founded in October 2024.
- What is Diastole's primary focus?
- Diastole is developing an innovative software platform that combines ultrasound Doppler technology and AI to provide rapid, accurate, and low-risk detection of coronary disease.
- What is Diastole's current funding stage?
- Diastole is currently in the Pre-Seed funding stage.
- When did Diastole complete its last funding round?
- Diastole completed a Pre-Seed funding round in July 2025.
- How many employees does Diastole currently have?
- Diastole currently has 5 employees.
- Where is Diastole headquartered?
- Diastole is headquartered in Tel Aviv-Yafo, Israel.
- Who are the founders of Diastole?
- The founders of Diastole are Guy Masad and Dan Pri-Tal.
- What sector does Diastole operate in?
- Diastole operates in the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical WorkflowDigital Medical Diagnostics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatients
Business model
B2B
Highlights
Verified
Tags
diagnosticsultrasoundheart-failureheart-diseasesstealthmode